Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...

Endocarditis I: Introduction

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spontaneous gastric balloon hyperinflation causing renal infarct.

iGIE : innovation, investigation and insights·2026

Same author

The natural history of osteogenesis imperfecta: a systematic review.

Bone reports·2026

Same author

Impact of bariatric surgery on alcohol-use disorder and alcohol-related liver disease: A retrospective study.

Addiction (Abingdon, England)·2026

Same author

Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth (SIBO).

JGH open : an open access journal of gastroenterology and hepatology·2026

Same author

Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults.

Infection·2026

Same author

Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey.

Drug and alcohol review·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A

Andrew Palmer^1,2,3, Matthew Carter², Jeremy Yeo^1,2,3

¹Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

The Medical Journal of Australia

|June 14, 2026

Summary

This summary is machine-generated.

Hospital-admitted injection-related infections in incarcerated individuals lead to significant illness and high healthcare costs. Findings highlight a substantial burden of preventable disease, supporting prison-based harm reduction strategies.

Keywords:

bacterial infections cost of illness hepatitis C mycobacterium prevention and control prison public health public policy social justice substance abuse

Related Experiment Videos

Last Updated: Jun 16, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Area of Science:

Infectious Diseases
Public Health
Health Economics

Background:

Injection-related infections (IRIs) pose a significant health challenge for incarcerated populations.
People who inject drugs (PWID) in custody experience unique vulnerabilities to infections.
Understanding the burden of IRIs in prisons is crucial for public health interventions.

Purpose of the Study:

To characterize the clinical, microbiological, and economic burden of hospital-admitted IRIs among incarcerated PWID.
To identify common pathogens and treatment requirements for IRIs in this population.
To estimate the healthcare costs associated with IRIs in custodial settings.

Main Methods:

Retrospective observational cohort study conducted at Princess Alexandra Hospital, Brisbane, Australia.
Included adult incarcerated individuals admitted with IRIs between July 2019 and June 2023.
Analyzed infection types, microbiology, need for source control, length of stay, and inpatient costs.

Main Results:

321 admissions for IRIs among 265 patients, with soft tissue infections, acute hepatitis C, and cellulitis being most common.
Hepatitis C virus (HCV) RNA detected in 40.4% of infections.
Significant healthcare costs, totaling $8.39 million, with a median cost of $11,602 per infection.
Atypical pathogens like Burkholderia species were identified.

Conclusions:

IRIs among incarcerated PWID represent a substantial burden of morbidity and healthcare costs.
The spectrum of infections includes common and atypical pathogens, and clinically overt acute hepatitis C.
Findings underscore the need for primary prevention and harm-reduction interventions within correctional facilities.